ACUT
ACCUSTEM SCIENCES INC by Accustem Sciences Inc. (ACUT)
$70
About ACCUSTEM SCIENCES INC by Accustem Sciences Inc. (ACUT)
AccuStem Sciences, Inc. is a clinical stage diagnostics company, which engages in medical practice activities. It also focuses on commercialization of a proprietary genomic test, StemPrintER, for patients with early-stage breast cancer. The company was founded by Gabriele Marco Antonio Cerrone on June 5, 2020 and is headquartered in New York, NY.
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$2.33
52 Week Low
$0.22
Market cap
11.3M
Dividend yield
0.00%
Volume
94
Avg. volume
614
P/E ratio
-6.02
ACCUSTEM SCIENCES INC by Accustem Sciences Inc. News
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$2.33
52 Week Low
$0.22
Market cap
11.3M
Dividend yield
0.00%
Volume
94
Avg. volume
614
P/E ratio
-6.02